中文

Vitamin C Tablets

【Specification】0. 1g

【Approval Number】CFDA NO. H20053399

【Chinese Medical Insurance Category】B

【Validity】24 months

【Indications】(1) For prevention and treatment of scurvy or as part of adjuvant therapy for various acute and chronic infectious diseases, purpura, etc. Patients with Keshan disease can be given large amounts of this product when they are in cardiogenic shock. (2) For treatment of chronic iron poisoning (vitamin C increases the excretion of iron in the presence of deferoxamine). (3) For effective treatment of idiopathic methemoglobinemia. (4) For treatment of liver cirrhosis, acute hepatitis and liver damage from chronic arsenic, mercury, lead and benzene poisoning.

【Administration and Dosage】Oral administration. For adults. (1) As a dietary supplement: 50-100mg per day. (2) For chronic dialysis patients: 100-200mg per day. (3) Lack of vitamin C: 3 times daily (100-200mg each time) for at least 2 weeks. For children: 100-300mg daily for at least two weeks. (4) Acidified urine: 4-12g per day orally in divided doses every 4 hours. (5) Idiopathic methemoglobinemia: 300-600mg daily in divided doses.

 

The drug instructions above are for drugs sold in the mainland of the People's Republic of China only. For any updated information, please refer to the latest versions approved by the China Food and Drug Administration. The instructions are not drug ads, and are only a reference for pharmacist and physician professionals. The information contained on the website is provided as a source of knowledge only, and should not replace medical advice from and medical consultation with doctors or other eligible medical professionals. The information on the page should not be used for the diagnosis of diseases.
Copyright © 2017 Chunfeng Pharmaceutical. All rights reserved. Beijing ICP No. 17022283